ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 0.2% of SONN shares are held by financial institutions. TOWER RESEARCH CAPITAL LLC (TRC) is the top corporate investor, holding 0 shares valued at -. A 0% stake in Sonnet BioTherapeutics Holdings, Inc. is owned by the company. BANK OF AMERICA CORP /DE/ owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the SONN insiders holding of 1.38% of the stake in company, MOHAN PANKAJ, Chairman, President and CEO, holds the largest shares of 59.53K. KENNEY RICHARD T, Chief Medical Officer, is the second largest SONN insider with ownership of 50K shares. SPITCAUFSKY LARRY, , stands third with possession of 40K shares of that stake.